
Apyx Medical Corporation (APYX) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Apyx Medical Corporation.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerAPYX Technical Analysis Summary
Apyx Medical Corporation stock currently shows a bullish trend, supported by momentum and strong buying pressure.
This mix signals that Apyx Medical Corporation is trading in a balanced range with no clear breakout yet.
RSI (14): 62.05
Stochastic %K: 59.59
Williams %R: -10.80
Rate of Change (ROC): 11.73
Takeaway:Apyx Medical Corporation shows steady upward momentum, supported by improving signals.
MACD: 0.13
ADX: 25.03
ATR (14): 0.33
CCI (14): 233.75
Takeaway:Apyx Medical Corporation shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Apyx Medical Corporation trades near the upper band, signaling overbought conditions and risk of pullback.
Takeaway:Apyx Medical Corporation trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:APYX shows mixed signals in money flow analysis.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
Price near upper Bollinger Band → potential resistance and pullback risk.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Apyx Medical Corporation currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.